{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:56:29Z","timestamp":1777607789977,"version":"3.51.4"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,5,1]]},"abstract":"<jats:p>The heptavalent pneumococcal conjugate vaccine (PCV7) has been shown to reduce the incidence of acute otitis media (AOM) caused by Streptococcus pneumoniae by 34% and reduces the overall incidence of AOM by 6% to 8%. More recent studies have shown increases in the proportion of Haemophilus influenzae and Moraxella catarrhalis in the middle-ear fluid of PCV7-immunized children. There has been no report on the effect of PCV7 on all 3 bacterial pathogens combined, either in the middle-ear fluid or nasopharynx of individual children with AOM. We investigated the impact of PCV7 on nasopharyngeal colonization with bacterial pathogens during AOM in the pre-PCV7 and post-PCV7 vaccination eras. Four hundred seventeen children (6 months to 4 years of age) were enrolled onto AOM studies between September 1995 and December 2004. Of these, 200 were enrolled before the vaccine use (historical controls), and 217 were enrolled after the initiation of PCV7 vaccination (101 were underimmunized, and 116 were immunized). Although the nasopharyngeal colonization rate for S pneumoniae was not different between the 3 groups, a significantly higher proportion of PCV7-immunized children with AOM were colonized with M catarrhalis. Overall, the mean number of pathogenic bacteria types isolated from immunized children (1.7) was significantly higher than in controls (1.4). The increase in bacterial colonization of the nasopharynx during AOM could be associated with an increase in AOM pathogens and theoretically can predispose PCV7-immunized children with AOM to a higher rate of antibiotic treatment failure or recurrent AOM.<\/jats:p>","DOI":"10.1542\/peds.2005-1983","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T17:22:05Z","timestamp":1146504125000},"page":"1823-1829","source":"Crossref","is-referenced-by-count":81,"title":["Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Bacterial Colonization During Acute Otitis Media"],"prefix":"10.1542","volume":"117","author":[{"given":"Krystal","family":"Revai","sequence":"first","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"McCormick","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janak","family":"Patel","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Grady","sequence":"additional","affiliation":[{"name":"Preventive Medicine and Community Health and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kokab","family":"Saeed","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasnee","family":"Chonmaitree","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics"},{"name":"Pathology, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2006,5,1]]},"reference":[{"key":"2021120823252126800_R1","doi-asserted-by":"crossref","unstructured":"Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J.\u20081997;16:449\u2013456","DOI":"10.1097\/00006454-199704000-00029"},{"key":"2021120823252126800_R2","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics.\u20082000;106:362\u2013366","DOI":"10.1542\/peds.106.2.362"},{"key":"2021120823252126800_R3","doi-asserted-by":"crossref","unstructured":"Wald ER, Mason EO Jr, Bradley JS, Barson WJ, Kaplan SL. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997. Pediatr Infect Dis J.\u20082001;20:34\u201339","DOI":"10.1097\/00006454-200101000-00007"},{"key":"2021120823252126800_R4","doi-asserted-by":"crossref","unstructured":"Block SL, Hedrick J, Harrison CJ, et al. Pneumococcal serotypes from acute otitis media in rural Kentucky. Pediatr Infect Dis J.\u20082002;21:859\u2013865","DOI":"10.1097\/00006454-200209000-00015"},{"key":"2021120823252126800_R5","doi-asserted-by":"crossref","unstructured":"Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media [Summary for patients in: Can Fam Physician. 2002;48:1777\u20131779]. N Engl J Med.\u20082001;344:403\u2013409","DOI":"10.1056\/NEJM200102083440602"},{"key":"2021120823252126800_R6","unstructured":"Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J.\u20082000;19:187\u2013195"},{"key":"2021120823252126800_R7","doi-asserted-by":"crossref","unstructured":"Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995\u20132003. Pediatr Infect Dis J.\u20082004;23:824\u2013828","DOI":"10.1097\/01.inf.0000136871.51792.19"},{"key":"2021120823252126800_R8","doi-asserted-by":"crossref","unstructured":"Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J.\u20082004;23:829\u2013833","DOI":"10.1097\/01.inf.0000136868.91756.80"},{"key":"2021120823252126800_R9","doi-asserted-by":"crossref","unstructured":"Talbot TR, Poehling KA, Hartert TV, et al. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tennessee after introduction of the pneumococcal conjugate vaccine. Clin Infect Dis.\u20082004;39:641\u2013648","DOI":"10.1086\/422653"},{"key":"2021120823252126800_R10","doi-asserted-by":"crossref","unstructured":"Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet.\u20082003;361:2189\u20132195","DOI":"10.1016\/S0140-6736(03)13772-5"},{"key":"2021120823252126800_R11","doi-asserted-by":"crossref","unstructured":"Ghaffar F, Barton T, Lozano J, et al. Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life. Clin Infect Dis.\u20082004;39:930\u2013938","DOI":"10.1086\/423379"},{"key":"2021120823252126800_R12","unstructured":"Faden H, Stanievich J, Brodsky L, Bernstein J, Ogra PL. Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J.\u20081990;9:623\u2013626"},{"key":"2021120823252126800_R13","doi-asserted-by":"crossref","unstructured":"McCormick DP, Saeed K, Uchida T, et al. Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol.\u20082003;67:221\u2013230","DOI":"10.1016\/S0165-5876(02)00372-5"},{"key":"2021120823252126800_R14","doi-asserted-by":"crossref","unstructured":"Chonmaitree T, Saeed K, Uchida T, et al. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr.\u20082003;143:377\u2013385","DOI":"10.1067\/S0022-3476(03)00293-2"},{"key":"2021120823252126800_R15","doi-asserted-by":"crossref","unstructured":"McCormick DP, Chonmaitree T, Pittman C, et al. Non-severe acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. Pediatrics.\u20082005;115:1455\u20131465","DOI":"10.1542\/peds.2004-1665"},{"key":"2021120823252126800_R16","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Committee on Infectious Diseases. Recommended childhood and adolescent immunization schedule: United States, July\u2013December 2004. Pediatrics.\u20082004;113:1448","DOI":"10.1542\/peds.113.5.1448"},{"key":"2021120823252126800_R17","doi-asserted-by":"crossref","unstructured":"From the Centers for Disease Control and Prevention. Updated Recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage: Advisory Committee on Immunization Practices. JAMA.\u20082002;287:833\u2013834","DOI":"10.1001\/jama.287.7.833"},{"key":"2021120823252126800_R18","doi-asserted-by":"crossref","unstructured":"Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in 2 Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J.\u20082004;23:1015\u20131022","DOI":"10.1097\/01.inf.0000143645.58215.f0"},{"key":"2021120823252126800_R19","doi-asserted-by":"crossref","unstructured":"McEllistrem MC, Adams JM, Patel K, et al. Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis.\u20082005;40:1738\u20131744","DOI":"10.1086\/429908"},{"key":"2021120823252126800_R20","doi-asserted-by":"crossref","unstructured":"Sanders CC, Sanders WE Jr, Harrowe DJ. Bacterial interference: effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect Immun.\u20081976;13:808\u2013812","DOI":"10.1128\/iai.13.3.808-812.1976"},{"key":"2021120823252126800_R21","doi-asserted-by":"crossref","unstructured":"Tano K, Olofsson C, Grahn-Hakansson E, Holm SE. In vitro inhibition of S pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children. Int J Pediatr Otorhinolaryngol.\u20081999;47:49\u201356","DOI":"10.1016\/S0165-5876(98)00174-8"},{"key":"2021120823252126800_R22","doi-asserted-by":"crossref","unstructured":"Bogaert D, van Belkum A, Sluijter M, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet.\u20082004;363:1871\u20131872","DOI":"10.1016\/S0140-6736(04)16357-5"},{"key":"2021120823252126800_R23","doi-asserted-by":"crossref","unstructured":"Duffy LC, Faden H, Wasielewski R, Wolf J, Krystofik D. Exclusive breastfeeding protects against bacterial colonization and day care exposure to otitis media. Pediatrics.\u20081997;100(4). Available at: www.pediatrics.org\/cgi\/content\/full\/100\/4\/e7","DOI":"10.1542\/peds.100.4.e7"},{"key":"2021120823252126800_R24","unstructured":"Bluestone CD, Klein JO. Physiology, pathophysiology and pathogenesis. In: Bluestone CD, Klein JO, eds. Otitis Media in Infants and Children. Philadelphia, PA: WB Saunders; 1995:17\u201337"},{"key":"2021120823252126800_R25","doi-asserted-by":"crossref","unstructured":"Chonmaitree T, Heikkinen T. Role of viruses in middle-ear disease. Ann N Y Acad Sci.\u20081997;830:143\u2013157","DOI":"10.1111\/j.1749-6632.1997.tb51886.x"},{"key":"2021120823252126800_R26","unstructured":"Howie VM, Ploussard JH. Simultaneous nasopharyngeal and middle ear exudate culture in otitis media. Pediatr Dig.\u20081971;13:31\u201335"},{"key":"2021120823252126800_R27","doi-asserted-by":"crossref","unstructured":"Gehanno P, Lenoir G, Barry B, Bons J, Boucot I, Berche P. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children. Pediatr Infect Dis J.\u20081996;15:329\u2013332","DOI":"10.1097\/00006454-199604000-00009"},{"key":"2021120823252126800_R28","doi-asserted-by":"crossref","unstructured":"Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J.\u20082001;20:1105\u20131107","DOI":"10.1097\/00006454-200112000-00002"},{"key":"2021120823252126800_R29","doi-asserted-by":"crossref","unstructured":"Libson S, Dagan R, Greenberg D, et al. Nasopharyngeal carriage of Streptococcus pneumoniae at the completion of successful antibiotic treatment of acute otitis media predisposes to early clinical recurrence. J Infect Dis.\u20082005;191:1869\u20131875","DOI":"10.1086\/429918"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/1823\/1070215\/zpe00506001823.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/117\/5\/1823\/1070215\/zpe00506001823.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T03:51:08Z","timestamp":1639021868000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/5\/1823\/70027\/Effect-of-Pneumococcal-Conjugate-Vaccine-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,1]]},"references-count":29,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,5,1]]},"published-print":{"date-parts":[[2006,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1983","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,1]]}}}